DURHAM, N.C., February 14, 2025--(BUSINESS WIRE)--MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants.
announced that the US Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 is the company’s lightest and smallest behind-the-ear audio ...